[go: up one dir, main page]

TWI480039B - Aqueous composition for contact lens - Google Patents

Aqueous composition for contact lens Download PDF

Info

Publication number
TWI480039B
TWI480039B TW100108129A TW100108129A TWI480039B TW I480039 B TWI480039 B TW I480039B TW 100108129 A TW100108129 A TW 100108129A TW 100108129 A TW100108129 A TW 100108129A TW I480039 B TWI480039 B TW I480039B
Authority
TW
Taiwan
Prior art keywords
vitamin
liquid composition
concentration
weight
contact lens
Prior art date
Application number
TW100108129A
Other languages
Chinese (zh)
Other versions
TW201236676A (en
Inventor
Hanyi Chang
Yahui Chang
Weijia Ting
Original Assignee
Pegavision Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pegavision Corp filed Critical Pegavision Corp
Priority to TW100108129A priority Critical patent/TWI480039B/en
Priority to CN201110339404XA priority patent/CN102670641A/en
Priority to JP2012012877A priority patent/JP2012189993A/en
Publication of TW201236676A publication Critical patent/TW201236676A/en
Application granted granted Critical
Publication of TWI480039B publication Critical patent/TWI480039B/en

Links

Landscapes

  • Eyeglasses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)

Description

一種用於隱形眼鏡之液態組成物Liquid composition for contact lenses

本發明是有關於一種用於隱形眼鏡之液態組成物。This invention relates to a liquid composition for contact lenses.

隨著人類文明及教育的普及與發展,愈來愈多人罹患近視。在考慮方便性及習慣性下,隱形眼鏡使用率甚高。使用隱形眼鏡必須進行清潔及保養,否則可能因隱形眼鏡上的微生物或污染物而讓眼球受傷。With the popularization and development of human civilization and education, more and more people suffer from myopia. The contact lens usage rate is very high considering convenience and habit. Use of contact lenses must be cleaned and maintained, otherwise eyeballs may be injured by microbes or contaminants on the contact lenses.

通常隱形眼鏡的保養方法是利用含有界面活性劑的隱形眼鏡清洗液來清潔鏡片。在清潔步驟之後,通常隱形眼鏡浸泡在一溶液中以便除去鏡片上的殘餘物。此外,保養方法包括消毒鏡片,以除去鏡片上可能的微生物。習知的隱形眼鏡保養液已可對隱形眼鏡提供良好的清潔及抗菌效果。The usual method of maintaining contact lenses is to clean the lens with a contact lens cleaning solution containing a surfactant. After the cleaning step, the contact lens is typically immersed in a solution to remove residue from the lens. In addition, maintenance methods include sterilizing the lens to remove possible microorganisms from the lens. Conventional contact lens maintenance solutions have provided good cleaning and antibacterial effects on contact lenses.

但是長時間配戴隱形眼鏡,容易引起眼睛疲勞不適,習知的隱形眼鏡保養液無法有效改善上述情形。因此,目前仍需一種隱形眼鏡保養液,其能消除隱形眼鏡使用者的眼球疲勞不適感。However, wearing contact lenses for a long time is prone to eye fatigue and discomfort. The conventional contact lens maintenance solution cannot effectively improve the above situation. Therefore, there is still a need for a contact lens maintenance solution that can eliminate eye contact fatigue discomfort of a contact lens user.

本發明之一目的係提供一種用於隱形眼鏡之液態組成物,俾能讓使用者在使用隱形眼鏡時,消除或舒緩眼球疲勞感,同時兼具隱形眼鏡保濕功能。It is an object of the present invention to provide a liquid composition for a contact lens which allows a user to eliminate or soothe eye fatigue when using a contact lens, and at the same time has a moisturizing function of the contact lens.

根據本發明之實施方式,上述用於隱形眼鏡之液態組成物包含重量百分濃度約1×10-5 %至約3%之一種或一種以上之維生素,重量百分濃度約5×10-3 %至約1.0%之一種或一種以上之親水性高分子,重量百分濃度約1×10-3 %至約1%之一種或一種以上之介面活性劑,以及一硼酸鹽緩衝溶液或磷酸鹽緩衝溶液。According to an embodiment of the present invention, the liquid composition for a contact lens comprises at least 1×10 -5 % to about 3% by weight of one or more vitamins, and the concentration by weight is about 5×10 -3 . % to about 1.0% of one or more hydrophilic polymers, at a concentration of from about 1 x 10 -3 % to about 1% by weight of one or more surfactants, and a borate buffer solution or phosphate Buffer solution.

依據本發明一實施例,維生素包含維生素A,且維生素A之重量百分濃度為約0.01%至約1%。According to an embodiment of the invention, the vitamin comprises vitamin A and the concentration of vitamin A is from about 0.01% to about 1% by weight.

依據本發明一實施例,維生素包含維生素B群,例如維生素B3、維生素B6或維生素B12,且維生素群之重量百分濃度為約0.01%至約1.5%。According to an embodiment of the invention, the vitamin comprises a vitamin B group, such as vitamin B3, vitamin B6 or vitamin B12, and the vitamin group has a concentration by weight of from about 0.01% to about 1.5%.

依據本發明一實施例,維生素包含維生素E,且維生素E之重量百分濃度為約0.01%至約1%。According to an embodiment of the invention, the vitamin comprises vitamin E and the concentration of vitamin E is from about 0.01% to about 1% by weight.

依據本發明一實施例,親水性高分子係選自由聚乙烯醇、聚乙烯吡咯烷酮、玻尿酸、羥丙基甲基纖維素以及聚乙二醇所組成之群組。親水性高分子之重量百分濃度為約0.01%至約0.1%。According to an embodiment of the present invention, the hydrophilic polymer is selected from the group consisting of polyvinyl alcohol, polyvinylpyrrolidone, hyaluronic acid, hydroxypropylmethylcellulose, and polyethylene glycol. The hydrophilic polymer has a weight percent concentration of from about 0.01% to about 0.1%.

依據本發明一實施例,介面活性劑包含至少一TWEEN 80TM 及GEROPONTM SBFA-30,且介面活性劑之重量百分濃度為約0.001%至約0.08%。According to an embodiment of the present invention, the interface comprises at least one active agent and TWEEN 80 TM GEROPON TM SBFA-30, and the weight percent concentration of interface active agent is from about 0.001% to about 0.08%.

依據本發明一實施例,硼酸鹽緩衝溶液包含硼酸、硼酸鈉以及氯化鈉。磷酸鹽緩衝溶液包含磷酸一氫鈉、磷酸二氫鈉以及氯化鈉。According to an embodiment of the invention, the borate buffer solution comprises boric acid, sodium borate, and sodium chloride. The phosphate buffer solution contains sodium monohydrogen phosphate, sodium dihydrogen phosphate, and sodium chloride.

為了使本揭示內容的敘述更加詳盡與完備,下文針對了本發明的實施態樣與具體實施例提出了說明性的描述;但這並非實施或運用本發明具體實施例的唯一形式。以下所揭露的各實施例,在有益的情形下可相互組合或取代,而無須進一步的記載或說明。在以下描述中,將詳細敘述許多特定細節以使讀者能夠充分理解以下的實施例。然而,可在無此等特定細節之情況下實踐本發明之實施例。The description of the embodiments of the present invention is intended to be illustrative and not restrictive. The various embodiments disclosed below may be combined or substituted with each other in a beneficial situation without further description or description. In the following description, numerous specific details are set forth However, embodiments of the invention may be practiced without these specific details.

本發明揭露一種用於隱形眼鏡之液態組成物,此液態組成物可使用在硬式隱形眼鏡及軟式隱形眼鏡。軟式隱形眼鏡鏡片可例如為親水性水膠鏡片或是矽高分子軟性隱形眼鏡。The present invention discloses a liquid composition for a contact lens that can be used in hard contact lenses and soft contact lenses. The soft contact lens can be, for example, a hydrophilic water gel lens or a silicone soft contact lens.

在通常使用情況下,隱形眼鏡是浸泡在液態組成物中,使隱形眼鏡與液態組成物充分接觸。當隱形眼鏡使用者欲配戴或使用隱形眼鏡時,才將隱形眼鏡從液態組成物中取出,然後再將隱形眼鏡配戴在眼球上。當隱形眼鏡浸泡在液態組成物時,液態組成物中的成分會附著或吸附在隱形眼鏡上。當使用者將隱形眼鏡配戴在的眼球上時,附著或吸附在隱形眼鏡上的成分便會進入到眼球中。In normal use, the contact lens is immersed in a liquid composition to provide sufficient contact between the contact lens and the liquid composition. When the contact lens user wants to wear or use the contact lens, the contact lens is taken out of the liquid composition, and then the contact lens is worn on the eyeball. When the contact lens is immersed in the liquid composition, the components of the liquid composition adhere or adhere to the contact lens. When the user wears the contact lens on the eyeball, the component attached or adsorbed on the contact lens enters the eyeball.

本發明實施方式的液態組成物至少包含維生素、親水性高分子、介面活性劑以及至少一硼酸鹽緩衝溶液或磷酸鹽緩衝溶液。The liquid composition of the embodiment of the present invention contains at least a vitamin, a hydrophilic polymer, an interfacial surfactant, and at least one borate buffer solution or a phosphate buffer solution.

維生素有助於消除隱形眼鏡使用者的眼球疲勞感。液態組成物中的維生素會吸附及附著在隱形眼鏡上,並隨著使用者配戴隱形眼鏡而進入眼球,而被眼球組織吸收。上 述維生素可為水溶性維生素或脂溶性維生素。水溶性維生素可例如為維生素B群;脂溶性維生素可例如為維生素A或維生素E。Vitamins help to eliminate the eye fatigue of contact lens users. The vitamins in the liquid composition are adsorbed and adhered to the contact lens, and enter the eyeball as the user wears the contact lens, and are absorbed by the eye tissue. on The vitamin may be a water-soluble vitamin or a fat-soluble vitamin. The water-soluble vitamin may be, for example, a vitamin B group; the fat-soluble vitamin may be, for example, vitamin A or vitamin E.

維生素在整體液態組成物中的重量百分濃度為約1×10-5 %至約3%。當液態組成物中維生素的濃度高於一定值時,會影響液態組成物的PH值,而使液態組成物的滲透壓過高。在此情況下,如果液態組成物進入眼球,會讓隱形眼鏡的使用者感到眼球不適。反之,當液態組成物的維生素濃度太低時,則無法產生消除眼球的疲勞的效果。因此,維生素的重量百分濃度為約1×10-5 %至約3%。從此一觀點而言,本發明實施方式所加入的維生素的總量,能讓液態組成物的PH值維持在約6.0至約8.0,液態組成物的滲透壓維持在約200mOsm/Kg至約500mOsm/Kg,較佳為約280mOsm/Kg至約380mOsm/Kg。The concentration of the vitamin in the bulk liquid composition is from about 1 x 10 -5 % to about 3% by weight. When the concentration of the vitamin in the liquid composition is higher than a certain value, the pH of the liquid composition is affected, and the osmotic pressure of the liquid composition is too high. In this case, if the liquid composition enters the eyeball, the user of the contact lens may feel uncomfortable. On the other hand, when the vitamin concentration of the liquid composition is too low, the effect of eliminating eye fatigue is not produced. Thus, the weight percent concentration of vitamins is from about 1 x 10 -5 % to about 3%. From this point of view, the total amount of vitamins added in the embodiment of the present invention allows the pH of the liquid composition to be maintained at about 6.0 to about 8.0, and the osmotic pressure of the liquid composition to be maintained at about 200 mOsm/kg to about 500 mOsm/ Kg is preferably from about 280 mOsm/kg to about 380 mOsm/kg.

在一實施例中,上述維生素包含維生素A,且維生素A之重量百分濃度為約0.01%至約1%。本文中,若無特別說明,重量百分濃度係以整體液態組成物為計算基準。In one embodiment, the vitamin comprises vitamin A and the concentration of vitamin A is from about 0.01% to about 1% by weight. Herein, unless otherwise specified, the weight percent concentration is based on the overall liquid composition.

在另一實施方式中,上述維生素包含維生素B群。在一實施例中,維生素包含維生素B3,且維生素B3之重量百分濃度為約0.01%至約1.5%。在另一實施例中,維生素包含維生素B6,且維生素B6之重量百分濃度為約0.01%至約1.5%。在又一實施例中,維生素包含維生素B12,且維生素B12之重量百分濃度為約0.01%至約1.5%。In another embodiment, the vitamin comprises a vitamin B population. In one embodiment, the vitamin comprises vitamin B3 and the concentration of vitamin B3 is from about 0.01% to about 1.5% by weight. In another embodiment, the vitamin comprises vitamin B6 and the weight percent concentration of vitamin B6 is from about 0.01% to about 1.5%. In yet another embodiment, the vitamin comprises vitamin B12 and the concentration by weight of vitamin B12 is from about 0.01% to about 1.5%.

在其他實施方式中,上述維生素包含維生素E,且維生素E之重量百分濃度為約0.01%至約1%。In other embodiments, the vitamin comprises vitamin E and the concentration of vitamin E is from about 0.01% to about 1% by weight.

親水性高分子可促使隱形眼鏡吸附更多的維生素,同時避免隱形眼鏡上的維生素因眼球的淚液而快速流失。液態組成物中的維生素,雖然能吸附在隱形眼鏡上,但是吸附量通常有限。液態組成物中的親水性高分子,可有效提高維生素在隱形眼鏡上的吸附及附著量。具體言之,液態組成物中的親水性高分子吸附在隱形眼鏡上,並與維生素發生吸附作用,而增加隱形眼鏡上維生素的吸附量。此外,親水性高分子有助於維持吸附在隱形眼鏡表面上的維生素,避免眼球產生的淚液將維生素從隱形眼鏡上溶解移除,而導致維生素迅速流失。尤其是在配戴隱形眼鏡時,隱形眼鏡接觸眼球的瞬間常伴隨著分泌大量淚液,若不能適當地維持隱形眼鏡上原本吸附的維生素,維生素將迅速地溶解在淚液中,並隨著淚液離開眼球而未被眼球吸收。從此一觀點而言,本發明並非僅是單純地添加維生素,而是關於維生素與親水性高分子之間的交互作用。更明確地說,本發明實施方式的技術內容是關於維生素、親水性高分子、隱形眼鏡、眼球以及淚液所形成生化系統,此係生化系統可讓使用者的眼球經由配戴隱形眼鏡而有效吸收維生素。Hydrophilic polymers can promote contact lenses to absorb more vitamins, while avoiding the rapid loss of vitamins on contact lenses due to tears in the eye. The vitamins in the liquid composition, although adsorbed on contact lenses, are usually limited in their amount of adsorption. The hydrophilic polymer in the liquid composition can effectively increase the adsorption and adhesion of vitamins on the contact lens. Specifically, the hydrophilic polymer in the liquid composition adsorbs on the contact lens and adsorbs with the vitamin, thereby increasing the amount of vitamins adsorbed on the contact lens. In addition, the hydrophilic polymer helps to maintain the vitamins adsorbed on the surface of the contact lens, preventing the tears generated by the eyeball from dissolving and removing the vitamins from the contact lens, resulting in rapid loss of vitamins. Especially when wearing contact lenses, the moment when the contact lens contacts the eyeball is often accompanied by the secretion of a large amount of tears. If the vitamins originally absorbed on the contact lens are not properly maintained, the vitamin will quickly dissolve in the tears and leave the eye with the tears. It is not absorbed by the eyeball. From this point of view, the present invention is not merely a simple addition of vitamins, but an interaction between a vitamin and a hydrophilic polymer. More specifically, the technical content of the embodiments of the present invention relates to a biochemical system formed by vitamins, hydrophilic polymers, contact lenses, eyeballs, and tears. The biochemical system allows the user's eyeball to be effectively absorbed by wearing contact lenses. Vitamins.

親水性高分子可例如為聚乙烯醇(Polyvinyl Alcohol,PVA)、聚乙烯吡咯烷酮(Polyvinylpyrrolidone,PVP)、玻尿酸(Hyaluronic acid,HA)、羥丙基甲基纖維素(Hydroxypropyl methylcellulose,HPMC)或聚乙二醇(Polyethylene glycol,PEG)。在一實施方式中,聚乙烯醇及聚乙烯吡咯烷酮的重量平均分子量為約2000g/mol至約50000g/mol,羥丙基甲 基纖維素及玻尿酸的重量平均分子量為約50000g/mol至約350000g/mol。上述親水性高分子亦有助於隱形眼鏡的保濕。The hydrophilic polymer may be, for example, polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), hyaluronic acid (HA), hydroxypropylmethylcellulose (HPMC) or polyethylene. Polyethylene glycol (PEG). In one embodiment, the polyvinyl alcohol and polyvinylpyrrolidone have a weight average molecular weight of from about 2000 g/mol to about 50,000 g/mol, hydroxypropyl group The weight average molecular weight of the base cellulose and hyaluronic acid is from about 50,000 g/mol to about 350,000 g/mol. The above hydrophilic polymer also contributes to the moisturizing of the contact lens.

親水性高分子在液態組成物中的濃度可根據維生素的種類及濃度調整。在一實施方式中,為使隱形眼鏡吸附足量的維生素,親水性高分子的重量百分濃度為約5×10-3 %至約0.5%,較佳為約0.01%至約0.1%。The concentration of the hydrophilic polymer in the liquid composition can be adjusted according to the type and concentration of the vitamin. In one embodiment, the hydrophilic polymer has a weight percent concentration of from about 5 x 10 -3 % to about 0.5%, preferably from about 0.01% to about 0.1%, in order for the contact lens to adsorb a sufficient amount of vitamins.

隱形眼鏡之液態組成物中可添加適量的介面活性劑,用以清潔隱形眼鏡。所添加介面活性劑的種類及濃度只要不會刺激使用者的眼球且無害於人體健康即可。例如,TWEEN 20TM 、TWEEN 80TM 、GEROPONTM SBFA-30或TETRONIC 1107TM ,介面活性劑重量百分濃度為約1×10-3 %至約1%,更明確地為約1×10-3 %至約0.1%。An appropriate amount of surfactant can be added to the liquid composition of the contact lens to clean the contact lens. The type and concentration of the added surfactant may be as long as it does not irritate the user's eye and is not harmful to human health. For example, TWEEN 20 TM, TWEEN 80 TM , GEROPON TM SBFA-30 or TETRONIC 1107 TM, the weight percent concentration of interface active agent is from about 1 × 10 -3% to about 1%, more specifically from about 1 × 10 -3 % to about 0.1%.

本發明之發明人發現,某些介面活性劑不只具有清潔隱形眼鏡的功能,且同時可促進隱形眼鏡吸附更多的維生素。在一實施例中,介面活性劑包含至少一TWEEN 80TM 及GEROPONTM SBFA-30的介面活性劑,其可更進一步提高隱形眼鏡上維生素的吸附量,並同時兼具清潔隱形眼鏡的功能。在本實施例中,介面活性劑在整體液態組成物中的重量百分濃度為約1×10-3 %至約0.08%,較佳為約0.002%至約0.01%。此外,TWEEN 80TM 及GEROPONTM SBFA-30介面活性劑可以增加脂溶性維生素在液態組成物中溶解度。The inventors of the present invention have found that certain surfactants not only have the function of cleaning contact lenses, but also promote the adsorption of more vitamins by the contact lenses. In one embodiment, the interface active agent comprises at least one active agent is TWEEN 80 TM interface and GEROPON TM SBFA-30, which can further increase the amount of adsorption on contact lenses vitamins and cleaning contact lenses while both functions. In this embodiment, the concentration of the surfactant in the bulk liquid composition is from about 1 x 10 -3 % to about 0.08%, preferably from about 0.002% to about 0.01%. Further, TWEEN 80 TM and GEROPON TM SBFA-30 interface active agent can increase the solubility of fat-soluble vitamins in the liquid composition.

硼酸鹽緩衝溶液或磷酸鹽緩衝溶液用以提供穩定的PH值環境。例如,硼酸鹽緩衝溶液可包含硼酸、硼酸鈉以 及氯化鈉。磷酸鹽緩衝溶液可包含磷酸一氫鈉、磷酸二氫鈉以及氯化鈉。此外,上述鹽類緩衝溶液包含適量的氯化鈉,使上述液態組成物的滲透壓維持在適當的範圍,例如為約200mOsm/Kg至約500mOsm/Kg。A borate buffer solution or a phosphate buffer solution is used to provide a stable pH environment. For example, the borate buffer solution may comprise boric acid, sodium borate to And sodium chloride. The phosphate buffer solution may comprise sodium monohydrogen phosphate, sodium dihydrogen phosphate, and sodium chloride. Further, the above salt buffer solution contains an appropriate amount of sodium chloride to maintain the osmotic pressure of the above liquid composition in an appropriate range, for example, from about 200 mOsm / Kg to about 500 mOsm / Kg.

在上述液態組成物包含硼酸鹽緩衝溶液的一實施方式中,氯化鈉在整體液態組成物中的重量百分濃度為約0.35%至約1.05%,硼酸的重量百分濃度為約0.20%至約0.70%,硼酸鈉的重量百分濃度為約0.01%至約0.7%。In one embodiment wherein the liquid composition comprises a borate buffer solution, the concentration by weight of sodium chloride in the bulk liquid composition is from about 0.35% to about 1.05%, and the concentration by weight of boric acid is from about 0.20% to About 0.70%, the weight percent concentration of sodium borate is from about 0.01% to about 0.7%.

在上述液態組成物包含磷酸鹽緩衝溶液的一實施方式中,氯化鈉在整體液態組成物中的重量百分濃度為約0.40%至約1.20%,磷酸一氫鈉的重量百分濃度為約0.10%至約0.70%,磷酸二氫鈉的重量百分濃度為約0.01%至約0.70%。In one embodiment wherein the liquid composition comprises a phosphate buffer solution, the weight percent concentration of sodium chloride in the overall liquid composition is from about 0.40% to about 1.20%, and the weight percent concentration of sodium monohydrogen phosphate is about From 0.10% to about 0.70%, the weight percent concentration of sodium dihydrogen phosphate is from about 0.01% to about 0.70%.

在其他實施方式中,上述液態組成物可更包含足量的抗微生物劑,例如可添加低於3ppm的聚六亞甲基雙胍(PHMB),其為本技術領域所習知。In other embodiments, the above liquid composition may further comprise a sufficient amount of antimicrobial agent, for example, less than 3 ppm of polyhexamethylene biguanide (PHMB) may be added, as is known in the art.

以下列出數個代表性實施例。Several representative embodiments are listed below.

實施例1Example 1

實施例2Example 2

實施例3Example 3

實施例4Example 4

實施例5Example 5

平衡物 水 Balance water

雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention, and the present invention can be modified and modified without departing from the spirit and scope of the present invention. The scope is subject to the definition of the scope of the patent application attached.

Claims (10)

一種用於隱形眼鏡之液態組成物,包含:重量百分濃度約1×10-5 %至約3%之一維生素;重量百分濃度約5×10-3 %至約1.0%之一親水性高分子,其中該親水性高分子係選自由聚乙烯醇、聚乙烯吡咯烷酮、玻尿酸、羥丙基甲基纖維素以及聚乙二醇所組成之群組;重量百分濃度約1×10-3 %至約1%之一介面活性劑;以及一硼酸鹽緩衝溶液或磷酸鹽緩衝溶液。A liquid composition for a contact lens comprising: a concentration by weight of from about 1 x 10 -5 % to about 3% of a vitamin; a concentration by weight of from about 5 x 10 -3 % to about 1.0% of a hydrophilicity a polymer, wherein the hydrophilic polymer is selected from the group consisting of polyvinyl alcohol, polyvinylpyrrolidone, hyaluronic acid, hydroxypropylmethylcellulose, and polyethylene glycol; and the concentration by weight is about 1×10 -3 From about 1% to about 1% of the surfactant; and a borate buffer solution or a phosphate buffer solution. 如請求項1所述之液態組成物,其中該維生素包含維生素A,且該維生素A之重量百分濃度為約0.01%至約1%。 The liquid composition of claim 1, wherein the vitamin comprises vitamin A, and the vitamin A is present in a concentration of from about 0.01% to about 1% by weight. 如請求項1所述之液態組成物,其中該維生素包含維生素B3,且該維生素B3之重量百分濃度為約0.01%至約1.5%。 The liquid composition of claim 1, wherein the vitamin comprises vitamin B3, and the vitamin B3 is present in a concentration of from about 0.01% to about 1.5% by weight. 如請求項1所述之液態組成物,其中該維生素包含維生素B6,且該維生素B6之重量百分濃度為約0.01%至約1.5%。 The liquid composition of claim 1, wherein the vitamin comprises vitamin B6, and the vitamin B6 has a concentration by weight of from about 0.01% to about 1.5%. 如請求項1所述之液態組成物,其中該維生素包含維生素B12,且該維生素B12之重量百分濃度為約0.01%至約1.5%。 The liquid composition of claim 1, wherein the vitamin comprises vitamin B12, and the vitamin B12 is present in a concentration of from about 0.01% to about 1.5% by weight. 如請求項1所述之液態組成物,其中該維生素包含維生素E,且該維生素E之重量百分濃度為約0.01%至約1%。 The liquid composition of claim 1, wherein the vitamin comprises vitamin E, and the vitamin E is present in a concentration of from about 0.01% to about 1% by weight. 如請求項1所述之液態組成物,其中該親水性高分子之重量百分濃度為約0.01%至約0.1%。 The liquid composition of claim 1, wherein the hydrophilic polymer has a concentration by weight of from about 0.01% to about 0.1%. 如請求項1所述之液態組成物,其中該介面活性劑包含至少一TWEEN 80TM 及GEROPONTM SBFA-30,且該介面活性劑之重量百分濃度為約0.001%至約0.08%。The liquid composition according to the request of the item 1, wherein the interface comprises at least one active agent and TWEEN 80 TM GEROPON TM SBFA-30, the interface and the weight percent concentration of the active agent of from about 0.001% to about 0.08%. 如請求項1所述之液態組成物,其中該硼酸鹽緩衝溶液包含硼酸、硼酸鈉以及氯化鈉。 The liquid composition of claim 1, wherein the borate buffer solution comprises boric acid, sodium borate, and sodium chloride. 如請求項1所述之液態組成物,其中該磷酸鹽緩衝溶液包含磷酸一氫鈉、磷酸二氫鈉以及氯化鈉。 The liquid composition of claim 1, wherein the phosphate buffer solution comprises sodium monohydrogen phosphate, sodium dihydrogen phosphate, and sodium chloride.
TW100108129A 2011-03-10 2011-03-10 Aqueous composition for contact lens TWI480039B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW100108129A TWI480039B (en) 2011-03-10 2011-03-10 Aqueous composition for contact lens
CN201110339404XA CN102670641A (en) 2011-03-10 2011-10-28 Liquid composition for contact lenses
JP2012012877A JP2012189993A (en) 2011-03-10 2012-01-25 Liquid composition for contact lenses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW100108129A TWI480039B (en) 2011-03-10 2011-03-10 Aqueous composition for contact lens

Publications (2)

Publication Number Publication Date
TW201236676A TW201236676A (en) 2012-09-16
TWI480039B true TWI480039B (en) 2015-04-11

Family

ID=46803629

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100108129A TWI480039B (en) 2011-03-10 2011-03-10 Aqueous composition for contact lens

Country Status (3)

Country Link
JP (1) JP2012189993A (en)
CN (1) CN102670641A (en)
TW (1) TWI480039B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673315B (en) * 2018-02-22 2019-10-01 優你康光學股份有限公司 Aqueous composition with the ability to release active ingredients and reusable contact lens products

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI634205B (en) * 2016-06-27 2018-09-01 晶碩光學股份有限公司 Solution for treating contact lens
TWI607768B (en) * 2017-03-31 2017-12-11 晶碩光學股份有限公司 Composition for contact lenses and method for caring contact lenses
KR102349146B1 (en) * 2017-08-30 2022-01-11 페가비젼 코포레이션 Contact lenses with device protection
JP7133942B2 (en) * 2018-02-27 2022-09-09 ロート製薬株式会社 ophthalmic composition
WO2020005416A1 (en) 2018-06-27 2020-01-02 Bausch & Lomb Incorporated Packaging solutions
TWI798452B (en) * 2019-06-17 2023-04-11 晶碩光學股份有限公司 Contact lens product
TWI854139B (en) * 2021-07-16 2024-09-01 晶碩光學股份有限公司 Liquid composition for storing contact lenses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1489480A (en) * 2001-01-09 2004-04-14 ·��˹��Լ�����ߺ��ɶ� Methods and compositions for treating and/or caring for the eye
TWI255715B (en) * 2001-12-20 2006-06-01 Bausch & Lomb Composition for treating contact lenses in the eye

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
JP3240193B2 (en) * 1992-10-01 2001-12-17 トーメー産業株式会社 Cleaning preservation solution for contact lenses and method for cleaning and disinfecting contact lenses using the same
JPH1072342A (en) * 1996-06-27 1998-03-17 Senju Pharmaceut Co Ltd Reduction in irritation of surfactant and low irritative aqueous composition
JPH11322627A (en) * 1998-05-07 1999-11-24 Nomura:Kk Antiallergic external composition for skin
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
JP2001158734A (en) * 1999-12-02 2001-06-12 Lion Corp Composition for ophthalmology and method for inhibiting adsorption to soft contact lens
JP2001302518A (en) * 2000-02-15 2001-10-31 Rohto Pharmaceut Co Ltd Method for improving action and agent for improving action
CN1326106A (en) * 2000-05-26 2001-12-12 盛岩 Special nursing liquid
JP5258139B2 (en) * 2000-11-08 2013-08-07 エフエックスエス・ベンチャーズ・エルエルシー Improved ophthalmic and contact lens solutions containing vitamin B form
US6634748B1 (en) * 2000-11-15 2003-10-21 Johnson & Johnson Vision Care, Inc. Methods of stabilizing silicone hydrogels against hydrolytic degradation
US7923469B2 (en) * 2001-04-30 2011-04-12 Allergen, Inc. Compositions including vitamin-based surfactants and methods for using same
US20040091613A1 (en) * 2002-11-13 2004-05-13 Wood Joe M. Methods for the extraction of contact lenses
JP5201795B2 (en) * 2005-01-12 2013-06-05 ロート製薬株式会社 Pruritus inhibitor
JP2007140219A (en) * 2005-11-21 2007-06-07 Tomey Corp Agent for contact lens
US7477366B2 (en) * 2006-12-07 2009-01-13 Coopervision International Holding Company, Lp Contact lens blister packages and methods for automated inspection of hydrated contact lenses
JP5616616B2 (en) * 2008-12-10 2014-10-29 ロート製薬株式会社 Eye drops for silicone hydrogel contact lenses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1489480A (en) * 2001-01-09 2004-04-14 ·��˹��Լ�����ߺ��ɶ� Methods and compositions for treating and/or caring for the eye
TWI255715B (en) * 2001-12-20 2006-06-01 Bausch & Lomb Composition for treating contact lenses in the eye

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673315B (en) * 2018-02-22 2019-10-01 優你康光學股份有限公司 Aqueous composition with the ability to release active ingredients and reusable contact lens products

Also Published As

Publication number Publication date
JP2012189993A (en) 2012-10-04
TW201236676A (en) 2012-09-16
CN102670641A (en) 2012-09-19

Similar Documents

Publication Publication Date Title
TWI480039B (en) Aqueous composition for contact lens
AU2002228449B2 (en) Procedure and composition of treatment and/or care of the eye
ES2374607T3 (en) Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid.
EP2666484B1 (en) Liquid preparation for contact lenses
KR20010031990A (en) Treatment of contact lenses with aqueous solution comprising an alkali carbonate
TW524697B (en) Compositions and methods for cleaning contact lenses
JP6871334B2 (en) Compositions for contact lenses and contact lens packages using them
CN103269686A (en) Ophthalmic composition for contact lens
JP4739022B2 (en) Ophthalmic composition
CN1942571A (en) Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions
WO2014114124A1 (en) Corneal contact lens nursing composition containing trehalose quaternary ammonium salt
JP2008510568A (en) Composition comprising trialkanolamine alkoxylate buffer
JP2021130007A (en) Composition for contact lens care
JP5401113B2 (en) Aqueous composition containing chlorous acid compounds containing menthols
JPWO2004084877A1 (en) Ophthalmic composition
TW548261B (en) Composition and method for inhibiting uptake of biguanide disinfectants by poly(ethylene)
CN101039705A (en) Compositions containing n,n,n',n'-tetrakis(hydroxyalkyl)diamine- or n,n,n',n'-tetrakis(hydroxyalkoxy) diamine-based buffers
JP4981181B1 (en) Contact lens composition
JP5587359B2 (en) Contact lens composition
JP2009199074A (en) Aqueous composition containing chlorous acid compound containing polyoxyethylene castor oil derivative and phosphoric acid compound
JP4817621B2 (en) Contact lens care method and composition
WO2014209939A2 (en) Lens care product for ozone-based cleaning/disinfecting of contact lenses
CN1302765C (en) Ophthalmic solution containing borneol and usage thereof
JP2006000170A (en) Contact lens composition
JP2009175731A (en) Chlorous acids compound-containing water-based composition containing glycerol and phosphoric acid compound